HEM-6131

K131742 · Omron Healthcare, Inc. · DXN · Jul 24, 2013 · Cardiovascular

Device Facts

• Record ID: K131742
• Device Name: HEM-6131
• Applicant: Omron Healthcare, Inc.
• Product Code: DXN · Cardiovascular
• Decision Date: Jul 24, 2013
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 870.1130
• Device Class: Class 2

Intended Use

The device is a digital monitor intended for use in measuring blood pressure and pulse rate in adult patient population with wrist circumference ranging from 5 1/4 inches to 8 1/2 inches (13.5 cm to 21.5 cm). The device detects the appearance of irregular heartbeats during measurement and gives a warning signal with readings.

Device Story

Automatic non-invasive wrist blood pressure monitor; battery-powered (2 AAA). Device inflates wrist cuff via integral pump; deflates via electronic valve. During inflation, device monitors cuff pressure and extracts pulse waveform data. Software analyzes waveform to determine systolic/diastolic pressure and pulse rate; detects irregular heartbeats. Memory function stores 60 measurements; displays average of last three. Used in home environment by adult patients. Healthcare providers review stored data or displayed readings to inform clinical decision-making regarding hypertension management. Benefits include convenient, self-administered blood pressure monitoring.

Clinical Evidence

Clinical accuracy study performed per ANSI/AAMI/ISO 81060-2. Study included 85 patients (36 male, 49 female). Reference method was standard auscultation in the left upper arm. Measurements were taken alternatively with the device and auscultation per AAMI sequence.

Technological Characteristics

Oscillometric blood pressure monitor. Piezo resistance pressure sensor. Powered by 2 AAA batteries. LCD display. Patient-contacting materials tested per ISO 10993-1 (cytotoxicity, sensitization, intracutaneous reactivity). Complies with AAMI SP10, IEC 60601-1, and IEC 60601-1-2.

Indications for Use

Indicated for adult patients with wrist circumference 13.5 cm to 21.5 cm for measurement of blood pressure and pulse rate. Includes irregular heartbeat detection.

Regulatory Classification

Identification

A noninvasive blood pressure measurement system is a device that provides a signal from which systolic, diastolic, mean, or any combination of the three pressures can be derived through the use of tranducers placed on the surface of the body.

Predicate Devices

• Omron HEM-609N (K042505)

Submission Summary (Full Text)

{0}------------------------------------------------

510(k) Summary K131742 Page 1 of 5

| Omron Healthcare, Inc.<br>1925 West Field Court<br>Lake Forest, IL 60045 USA | Tel - 847-247-5626<br>Fax- 847-680-6269 | | JUL 2 4 2003 |
|------------------------------------------------------------------------------|---------------------------------------------------------------------------------------|--|--------------|
| Official Contact: | Renee Thornborough - Director QA/RA | | |
| Proprietary or Trade Name: | Model HEM-6131 | | |
| Common/Usual Name: | Noninvasive blood pressure measurement system. | | |
| Classification Name/Code: | DXN - Noninvasive blood pressure measurement<br>system.<br>21CFR 870.1130<br>Class II | | |
| Device: | Model HEM-6131 | | |

Note that the device is sometimes referred to as the HEM-6131-LA in this submission, this is just an Omron internal name the HEM-6131 and HEM-6131-LA are identical

# Device Description:

The device is an automatic non-invasive blood pressure system. The device is battery powered by 2 "AAA" batteries, there is no connection to external power. The device inflates a wrist cuff with an integral pump, then deflates the cuff via an electronically controllable valve. During inflation the cuff pressure is monitored and pulse waveform data is extracted. The extracted pulse waveform data is then analyzed by software which determines pulse rate, as well as systolic and diastolic pressure. The algorithm used to determine pulse rate, systolic and diastolic pressure is identical to the predicate.

The device has a memory function that automatically stores up to 60 of the latest measurements. It can also display an average of the last three values

The device also detects the appearance of irregular heartbeats during measurement.

Intended User Home user

# Patient Population

{1}------------------------------------------------

510(k) Summary K131742 Page 2 of 5

This device is intended for use on adults.

## Indications for Use:

The device is a digital monitor intended for use in measuring blood pressure and pulse rate in adult patient population with wrist circumference ranging from 5 1/4 inches to 8 1/2 inches (13.5 cm to 21.5 cm).

The device detects the appearance of irregular heartbeats during measurement and gives a warning signal with readings.

Environment of Use: Home

Contraindications: There are no known contraindications.

#### Predicate Device Comparison:

The HEM-6131was compared to the predicate HEM-609N (k042505) in the device comparison table below.

{2}------------------------------------------------

Premarket Notification 510(k)
Section 5 – 510(k) Summary

Omron HEM-6131

510(k) Summary

:

Device Comparisor

| | Omron HEM-6131 | Omron HEM-609N 510(k) K042505 | Comment |
|--------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------|
| Indications for Use | The device is a digital monitor intended for use in measuring blood pressure and pulse rate in adult patient population with wrist circumference ranging from 5 1/4 inches to 8 1/2 inches (13.5 cm to 21.5 cm).<br>The device detects the appearance of irregular heartbeats during measurement and gives a warning signal with readings. | The device is a digital monitor intended for use in measuring blood pressure and pulse rate in adult patient population with wrist circumference ranging from 5 1/4 inches to 8 1/2 inches (13.5 cm to 21.5 cm).<br>The device detects the appearance of irregular heartbeats during measurement and gives a warning signal with readings. | Identical |
| Patient Population | Adult | Adult | Identical |
| Environment of Use | Home | Home | Identical |
| Prescriptive | OTC | No | Identical |
| Patient Connection | Yes via cuff | Yes via cuff | Identical |
| Technology | Oscillometric | Oscillometric | Identical |
| Measurement range | Pressure: 0-299 mmHg<br>Pulse rate: 40 to 180 bpm | Pressure: 0-299 mmHg<br>Pulse rate: 40 to 180 bpm | Identical |
| Accuracy or pressure indicator | +/-3 mmHg or 2% of reading | +/-3 mmllg | Similar |
| Pressure sensor | Piezo resistance sensor | Silicone capacitive sensor | Similar, identical function |
| Accuracy Pulse Rate | +/-5% | +/-5% | Identical |
| Inflation Method | Electric pump | Electric pump | Identical |
| Deflation Method | Internal valve | Internal valve | Identical |
| Display Type | LCD | LCD | Identical |
| Irregular pulse detection | Yes | Yes | Identical |
| Power Source | AAA batteries | AAA batteries | Identical |
| Operating Conditions | Temperature: 10° to 40° C<br>Humidity: 15 to 85% RH | Temperature: 10° to 40° C<br>Humidity: 30 to 85% RH | Similar |
| Storage Conditions | Temperature: -20° to 60° C<br>Humidity: 10 to 95% RH | Temperature: -20° to +60°C<br>Humidity: 10 to 95% RH | Identical |
| Dimensions | 78(W) x 60(D) x 21(H) mm | 70(W) x 54(D) x 37(H) mm | Similar |
| Weight | Approximately 101g | 110g | Similar |

Page 5.3

{3}------------------------------------------------

510(k) Summary K131742 Page 4 of 5

# Differences Between Other Legally Marketed Predicate Devices:

The Omron HEM-6131 is viewed as substantially equivalent to the predicate device because: The HEM-6131 uses the exact same technology and has identical indications for use. The differences that exist between the devices are insignificant in the terms of safety or effectiveness.

## Indications -

The indications for use measuring blood pressure and pulse rate in adult patient population with wrist circumference ranging from 5 1/4 inches to 8 1/2 inches (13.5 cm to 21.5 cm). The device detects the appearance of irregular heartbeats during measurement and gives a warning signal with readings.

Discussion ~ These indications are identical to the predicate Omron HEM-609N (k042505).

Prescriptive - The HEM-6131 and predicate are both OTC.

Design and Technology - The HEM-6131 has equivalent design and features as the predicate and has the identical technology to the predicate.

Performance and Specifications - The HEM-6131 has equivalent specifications of performance as the predicate.

Compliance with standards - The HEM-6131 and predicate device declare compliance with SP10, IEC 60601-1 and IEC 60601-1-2.

#### Materials -

The patient contacting materials of the cuffs has been tested in accordance with ISO 10993-1 and FDA Guidance. The tests included Cytotoxicity, Sensitization, and Intracutaneous Reactivity.

#### Patient Population -

The HEM-6131 and predicate are indicated for adults

#### Non-Clinical Testing Summary:

We have performed bench tests and found that the HEM-6131 met all requirements specifications and standards requirements and were found to be equivalent in comparison to the predicate. Testing includes the following:

- Verification Testing .
- . Testing for compliance to IEC 60601-1

{4}------------------------------------------------

510(k) Summary K131742 Page 5 of 5

- . Testing for compliance to IEC 60601-1-2
- . Testing for compliance to AAMI SP10
- . Comparative Testing to the Predicate

## Clinical Testing Summary:

Testing to insure clinical accuracy of the device in accordance with ANSI/AAMI/ISO 81060-2 as documented in Section 20.

Eighty five patients (36 males and 49 females) were recruited for the study. Standard auscultation method was used as the reference blood pressure (BP) measuring in the left upper arm. BP measurements were repeated alternatively with the device and auscultation in the same arm according to the sequence in AAMI.

## Substantial Equivalence Conclusion

Omron maintains that the HEM-6131 is substantially equivalent to the predicate HEM-609N (k042505) in indications for use, patient population, and environment for use, technology characteristics, specifications / performance and compliance with international standards

{5}------------------------------------------------

DEPARTMENT OF HEALTH & HUMAN SERVICES

Image /page/5/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo features a stylized eagle with its wings spread, and the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular pattern around the eagle. The logo is black and white and has a simple, clean design. The eagle is facing to the right.

Public Health Service

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-002

July 24, 2013

Omron Healthcare, Inc. c/o Mr. Paul Dryden Consultant 24301 Woodsage Drive Bonita Springs, FL 34134 US

Re: K131742

> Trade/Device Name: Hem-6131 Regulation Number: 21 CFR 870.1130 Regulation Name: Noninvasive Blood Pressure Measurement System Regulatory Class: Class II Product Code: DXN Dated: June 11, 2013 Received: June 13, 2013

Dear Mr. Paul Dryden:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must

{6}------------------------------------------------

Page 2 - Mr. Paul Dryden

comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, Misbranding by reference to premarket notification (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htmfor the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number [phone] or [phone] or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

# Owen P. Faris -S

for

Bram D. Zuckerman, Ph.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health

{7}------------------------------------------------

K131742

#### Indications for Use Statement

Page 1 of 1

(To be assigned) 510(k) Number:

Device Name:

Omron HEM-6131

Indications for Use:

The device is a digital monitor intended for use in measuring blood pressure and pulse rate in adult patient population with wrist circumference ranging from 5 1/4 inches to 8 1/2 inches (13.5 cm to 21.5 cm).

The device detects the appearance of irregular heartbeats during measurement and gives a warning signal with readings.

Environments of Use: Home Patient Population: Adult

Prescription Use (Part 21 CFR 801 Subpart D) or

Over-the-counter use XX (21 CFR 807 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Digitally signed by
Owen P. Faris -S
Date: 2013.07.24
14:08:08--04'00'